Trump's Psychedelics Executive Order Advances Research but Cannabis Reform Stalls
President Donald Trump's executive order on psychedelics aims to accelerate research and clinical trials for drugs like psilocybin and MDMA, but does not change their legal status. Cannabis reform efforts remain stalled as the Drug Enforcement Administration continues its review of rescheduling marijuana from Schedule I to Schedule III.
Topics: cannabis Drug Enforcement Administration (DEA) federal policy medical research psychedelics